Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q2 2019

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q2 2019” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q2 2019. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

Scope

Analysis of the market trends for the pharmaceutical industry in the global arena.

Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.

Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.

Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.

Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.

Analysis of partnership and licensing deals based on clinical stage of development of products.

Summary of the pharmaceutical deals globally in the five quarters.

Information on the top deals happened in the pharmaceutical industry.

Geographies covered include – North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.

League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

Enhance your decision making capability in a more rapid and time sensitive manner.

Find out the major deal performing segments for investments in your industry.

Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.

Identify companies that are aggressively looking to raise capital in the market

Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.

Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.

Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.

Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.

Identify growth segments and opportunities in each region within the industry.

Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Pharmaceuticals & Healthcare, Global, Deal ...

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q2 2019 10

2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q2 2019 10

2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q2 2019 12

2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q2 2019 13

2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q2 2019 14

2.4.1 AbbVie to Acquire Allergan 14

2.4.2 Pfizer to Acquire Array BioPharma 15

2.4.3 Bristol-Myers Squibb Raises USD19 Billion in Private Placement of Notes 16

2.4.4 Consortium of Investors to Acquire Nestle Skin Health from Nestle for USD10.11 Billion 16

2.4.5 Dassault Systemes to Acquire Medidata Solutions for USD5.8 Billion 17

3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 18

3.1 Pharmaceuticals & Healthcare, Global, M&A, Q2 2019 18

3.1.1 Top M&A Deals in Q2 2019 19

3.1.3 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q2 2018 - Q2 2019 20

3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q2 2019 21

3.2.1 Top Initial Public Offerings in Q2 2019 22

3.2.2 Top Secondary Offerings in Q2 2019 22

3.2.3 Top PIPE Deals in Q2 2019 23

3.2.4 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q2 2018 – Q2 2019 23

3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q2 2019 25

3.3.1 Top Venture Financing Deals in Q2 2019 26

3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q2 2019 26

3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q2 2019 27

3.3.5 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q2 2018 - Q2 2019 28

3.3.6 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Q2 2018 – Q2 2019 29

3.3.7 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q2 2018 – Q2 2019 30

3.5 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q2 2019 31

3.5.1 Top Private Equity Deals in Q2 2019 32

3.5.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q2 2018 - Q2 2019 32

4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q2 2019 34

4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q2 2019 34

4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q2 2018 - Q2 2019 36

4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2019 37

4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q2 2019 38

4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q2 2019 38

4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q2 2019 38

4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2018 - Q2 2019 39

4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q2 2018 - Q2 2019 40

4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q2 2018 - Q2 2019 41

4.8 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2018 - Q2 2019 42

5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q2 2019 44

5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q2 2019 44

5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q2 2018 - Q2 2019 45

5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q2 2019 46

5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q2 2019 46

5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q2 2019 47

5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q2 2018 - Q2 2019 48

5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q2 2018 - Q2 2019 49

5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q2 2018 - Q2 2019 51

5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q2 2018 - Q2 2019 52

5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q2 2018 - Q2 2019 53

6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 55

6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q2 2019 55

6.1.1 Oncology – Deals of the Quarter 56

6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q2 2019 59

6.2.1 Central Nervous System – Deals of the Quarter 60

6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q2 2019 62

6.3.1 Infectious Disease – Deals of the Quarter 63

6.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q2 2019 65

6.4.1 Immunology – Deals of the Quarter 66

6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q2 2019 68

6.5.1 Metabolic Disorders – Deals of the Quarter 69

6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q2 2019 71

6.6.1 Cardiovascular – Deals of the Quarter 72

6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q2 2019 74

6.7.1 Gastrointestinal – Deals of the Quarter 75

6.8 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q2 2019 77

6.8.1 Dermatology – Deals of the Quarter 78

6.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q2 2019 79

6.9.1 Respiratory – Deals of the Quarter 80

6.10 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q2 2019 81

6.10.1 Ophthalmology – Deals of the Quarter 82

7 Deal Summary by Geography 84

7.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q2 2019 84

7.1.1 North America – Deals of the Quarter 85

7.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q2 2019 87

7.2.1 Europe – Deals of the Quarter 88

7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q2 2019 90

7.3.1 Asia-Pacific – Deals of the Quarter 91

7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q2 2019 93

7.4.1 Rest of the World – Deals of the Quarter 94

8 Pharmaceuticals & Healthcare, Global, Top Advisors 96

8.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Q2 2018 - Q2 2019 96

8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Q2 2018 - Q2 2019 97

9 Further Information 98

9.1 Methodology 98

9.2 About GlobalData 99

9.3 Contact Us 99

9.4 Disclosure information 99

9.5 Disclaimer 100

List of Tables

1.1 List of Tables

Table 1: Pharmaceuticals & Healthcare, Global, Deal Summary, Number of Deals and Deal Values (US$m), Q2 2018 - Q2 2019 11 ...

1.1 List of Tables

Table 1: Pharmaceuticals & Healthcare, Global, Deal Summary, Number of Deals and Deal Values (US$m), Q2 2018 - Q2 2019 11

Table 2: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), Q2 2019 13

Table 3: Pharmaceuticals & Healthcare, Global, Top Deals, Q2 2019 14

Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 – Q2 2019 19

Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, Q2 2019 19

Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, , Q2 2018 - Q2 2019 20

Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$m), Q2 2018 - Q2 2019 22

Table 8: Pharmaceuticals & Healthcare, Global, Top Initial Public Offering Deals, Q2 2019 22

Table 9: Pharmaceuticals & Healthcare, Global, Top Secondary Offering Deals, Q2 2019 22

Table 10: Pharmaceuticals & Healthcare, Global, Top PIPE Deals, Q2 2019 23

Table 11: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$m), Q2 2018 - Q2 2019 24

Table 12: Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 25

Table 13: Pharmaceuticals & Healthcare, Global, Top Venture Capital Deals, Q2 2019 26

Table 14: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), Q2 2019 27

Table 15: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$m), Q2 2018 - Q2 2019 28

Table 16: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), Q2 2018 – Q2 2019 29

Table 17: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q2 2018 – Q2 2019 30

Table 18: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 – Q2 2019 31

Table 19: Pharmaceuticals & Healthcare, Global, Top Private Equity Deals, Q2 2019 32

Table 20: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$m), Q2 2018 - Q2 2019 33

Table 21: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 35

Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 36

Table 23: Pharmaceuticals & Healthcare, Partnership Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q2 2018 - Q2 2019 37

Table 24: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payments and Deal Values (US$ m), Q2 2019 38

Table 25: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q2 2019 38

Table 26: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, Q2 2019 38

Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), Q2 2018 - Q2 2019 39

Table 28: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q2 2018 - Q2 2019 41

Table 29: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payment and Deal Values (US$ m), Q2 2018 - Q2 2019 43

Table 30: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deal Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 44

Table 31: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront & Milestone Payments and Deal Values (US$ m), Q2 2018 - Q2 2019 45

Table 32: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Deal Values, Q2 2019 46

Table 33: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Total Upfront Payment, Q2 2019 46

Table 34: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals, by Total Milestone Payment, Q2 2019 47

Table 35: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 48

Table 36: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payment (US$ m), Q2 2018 - Q2 2019 50

Table 37: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q2 2018 - Q2 2019 52

Table 38: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payment and Deal Values (US$ m), Q2 2018 - Q2 2019 54

Table 39: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 56

Table 40: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 60

Table 41: Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 63

Table 42: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 66

Table 43: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 69

Table 44: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 72

Table 45: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 75

Table 46: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 78

Table 47: Pharmaceuticals & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 80

Table 48: Pharmaceuticals & Healthcare, Global, Ophthalmology, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 82

Table 49: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 85

Table 50: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 88

Table 51: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 91

Table 52: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 94

Table 53: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 96

Table 54: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 97

List of Figures

1.2 List of Figures

Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$m), Q2 2018 - Q2 2019 10

Figure 2: ...

1.2 List of Figures

Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$m), Q2 2018 - Q2 2019 10

Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), Q2 2019 12

Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), Q2 2019 13

Figure 4: Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$m), Q2 2018 - Q2 2019 18

Figure 5: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$m), by Therapy Area, Q2 2018 – Q2 2019 20

Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 21

Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$m), Q2 2018 – Q2 2019 23

Figure 8: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 25

Figure 9: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%), Q2 2019 26

Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Deal Values (%), Q2 2019 27

Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, Q2 2018 - Q2 2019 28

Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), Q2 2018 – Q2 2019 29

Figure 13: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), Q2 2018 – Q2 2019 31

Figure 14: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, Q2 2018 - Q2 2019 32

Figure 15: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 34

Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 36

Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront & Milestone Payment and Deal Values (US$ m), Q2 2018 - Q2 2019 37

Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), Q2 2018 - Q2 2019 39

Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q2 2018 - Q2 2019 40

Figure 20: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q2 2018 - Q2 2019 41

Figure 21: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payment and Deal Values (US$ m), Q2 2018 - Q2 2019 42

Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 44

Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2018 - Q2 2019 45

Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 48

Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront & Milestone Payments and Deal Values (US$ m), Q2 2018 - Q2 2019 49

Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Number Of Deals, Q2 2018 - Q2 2019 51

Figure 27: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Deal Values (US$ m), Q2 2018 - Q2 2019 52

Figure 28: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q2 2018 - Q2 2019 53

Figure 29: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 55

Figure 30: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 59

Figure 31: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 62

Figure 32: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 65

Figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 68

Figure 34: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 71

Figure 35: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 74

Figure 36: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 77

Figure 37: Pharmaceuticals & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 79

Figure 38: Pharmaceuticals & Healthcare, Global, Ophthalmology, Deals Summary, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 81

Figure 39: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 84

Figure 40: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 87

Figure 41: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 90

Figure 42: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 93

Figure 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 96

Figure 44: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q2 2018 - Q2 2019 97

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports

GlobalData fits right into our lean operating model without compromising the breadth and depth of research material

  Pathovax